Company: SXTPW
Filing Date: 2025-01-30
Form Type: 424B5
Source: 0001213900-25-008098
Chunk: 80

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 424B5
Chunk 80
---
, premium, if any, and interest, if any, with respect to such securities to be due and payable;                  |
| ● | additions                                                                                                                             
 to or changes in or deletions of the provisions relating to covenant defeasance and legal defeasance;                                 |
| ● | additions                                                                                                                             
 to or changes in the provisions relating to satisfaction and discharge of the indenture;                                              |
| ● | additions                                                                                                                             
 to or changes in the provisions relating to the modification of the indenture both with and without the consent of holders of debt    
 securities issued under the indenture;                                                                                                |

<div align='center'>25</div>

| ● | the currency of payment                                                                                                          
 of debt securities if other than U.S. dollars and the manner of determining the equivalent amount in U.S. dollars;               |
| ● | whether interest will be                                                                                                         
 payable in cash or additional debt securities at our or the holders’ option and the terms and conditions upon which the election 
 may be made;                                                                                                                     |
| ● | any restrictions on transfer,                                                                                                    
 sale or assignment of the debt securities of the series; and                                                                     |
| ● | any other specific terms,                                                                                                        
 preferences, rights or limitations of, or restrictions on, the debt securities, any other additions or changes in the provisions 
 of the indenture, and any terms that may be required by us or advisable under applicable laws or regulations.                    |

Conversion or Exchange Rights

We will set forth in the applicable prospectus supplement the terms on which a series of debt securities may be convertible into or exchangeable for our common stock or our other securities. We will include provisions as to settlement upon conversion or exchange and whether conversion or exchange is mandatory, at the option of the holder or at our option. We may include provisions pursuant to which the number of shares of our common stock or our other securities that the holders of the series of debt securities receive would be subject to adjustment.

Consolidation, Merger or Sale

Unless we provide otherwise in the prospectus supplement applicable to a particular series of debt securities, the indenture will not contain any covenant that restricts our ability to merge or consolidate, or sell, convey, transfer or otherwise dispose of our assets as an entirety or substantially as an entirety. However, any successor to or acquirer of such assets (other than a subsidiary of ours) must assume all of our obligations under the indenture or the debt securities, as appropriate.

Events of Default under the Indenture

Unless we provide otherwise in